Published in

Elsevier, Journal of Allergy and Clinical Immunology, 6(138), p. 1752-1755

DOI: 10.1016/j.jaci.2016.07.015

Links

Tools

Export citation

Search in Google Scholar

Efficacy of the Janus kinase 1/2 inhibitor ruxolitinib in the treatment of vasculopathy associated with TMEM173 -activating mutations in 3 children

This paper was not found in any repository, but could be made available legally by the author.
This paper was not found in any repository, but could be made available legally by the author.

Full text: Unavailable

Green circle
Preprint: archiving allowed
Green circle
Postprint: archiving allowed
Red circle
Published version: archiving forbidden
Data provided by SHERPA/RoMEO